Cargando…
Multi-drug resistance and reduced susceptibility to ciprofloxacin among Salmonella enterica serovar Typhi isolates from the Middle East and Central Asia
Typhoid fever is common in developing countries, with an estimated 120 million infections and 700 000 annual deaths, worldwide. Fluoroquinolones have been the treatment of choice for infection with multidrug-resistant (MDR) Salmonella enterica serovar Typhi (S. Typhi). However, alarming reports of f...
Autores principales: | Rahman, B A, Wasfy, M O, Maksoud, M A, Hanna, N, Dueger, E, House, B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184576/ https://www.ncbi.nlm.nih.gov/pubmed/25356352 http://dx.doi.org/10.1002/nmi2.46 |
Ejemplares similares
-
Emergence of Ciprofloxacin-Resistant Salmonella enterica Serovar Typhi in Italy
por: García-Fernández, Aurora, et al.
Publicado: (2015) -
Pitfalls of interpreting ciprofloxacin minimum inhibitory concentrations in Salmonella enterica serovar Typhi
por: Khan, Sadia, et al.
Publicado: (2012) -
Multi-drug resistant Salmonella enterica serovar Typhi isolates with reduced susceptibility to ciprofloxacin in Kenya
por: Mutai, Winnie C., et al.
Publicado: (2018) -
Decreased susceptibility to ciprofloxacin in Salmonella enterica serotype typhi, United Kingdom.
por: Threlfall, E J, et al.
Publicado: (2001) -
Transcriptomic study of Salmonella enterica subspecies enterica serovar Typhi biofilm
por: Chin, Khee Chian Jason, et al.
Publicado: (2017)